Skip to main content
. 2017 Dec 19;15(3):3313–3320. doi: 10.3892/ol.2017.7645

Table III.

2−ΔΔq values of VEGF-A mRNA expression following THD and L-OHP treatment.

Control group 50 µg/ml THD 64 mg/l L-OHP 50 µg/ml THD+ 64 mg/l L-OHP
1.002±0.074 0.685±0.035a 0.281±0.018a 0.167±0.007a
a

P<0.05 front group vs. the followed group. VEGF, vascular endothelial proliferation factor; THD, thalidomide; L-OHP, oxaliplatin.